Trials / Unknown
UnknownNCT03231449
A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Cardiologie et Développement · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
FEVRIER study is an observatory of hospitalizations in cardiology units in sub-Saharan Africa.
Detailed description
FEVRIER is an observational study based on a questionnaire completed by investigators for each hospitalization in cardiology unit during the month of February.The investigator is a physician of the participating hospital. FEVRIER evaluates the modalities of care management. It will take place in cardiology units of hospitals of sub-Saharian countries one month per year (month of February) during 5 years. The investigator will thoroughly complete: * one information form describing the hospital and the department * one questionnaire (2o questions) for each hospitalized patient Patients with at least one day of hospitalization will be enrolled in the study. On the first day of February, all patients already hospitalized will be enrolled and all patients hospitalized in the last day of February will be followed until their discharge. thus, data collection will start 1st day of investigation, during February and will continue until the discharge of the last enrolled patient.
Conditions
- Acute Coronary Syndrome
- Heart Failure
- Syncope
- Stroke
- Pericarditis
- Endocarditis
- Conduction Abnormalities
- Rhythm; Abnormal
- Pulmonary Embolism
- Deep Vein Thrombosis
- Other Cardiovascular Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | observation of current care | The study FEVRIER (survey of hospitalizations in cardiology units in sub-Saharan Africa) aims to establish a description of sub-Saharan standard of care, in order to get a cross sectional analysis (globally and per country) and a longitudinal analysis (evolution during 5 years). |
Timeline
- Start date
- 2017-02-01
- Primary completion
- 2020-12-01
- Completion
- 2021-02-01
- First posted
- 2017-07-27
- Last updated
- 2018-05-25
Locations
20 sites across 13 countries: Benin, Burkina Faso, Burundi, Cameroon, Côte d’Ivoire, Democratic Republic of the Congo, Gabon, Guinea, Mozambique, Niger, Republic of the Congo, Senegal, Sudan
Source: ClinicalTrials.gov record NCT03231449. Inclusion in this directory is not an endorsement.